Marker Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MRKR for the last quarter is 1.17 M USD, and it's 6.01% lower compared to the previous quarter. The net income of Q2 24 is -2.19 M USD.